Thermosensitive Liposome Formulated Indocyanine Green for Near-Infrared Triggered Photodynamic Therapy: In Vivo Evaluation for Triple-Negative Breast Cancer

Pharmaceutical Research

Volumn 32, Issue 5, 2015, Pages 1604-1614

  Shemesh, Colby S ^a   Moshkelani, Delaram ^a   Zhang, Hailing ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

indocyanine green; liposomes; near infrared florescence imaging; photodynamic therapy; triple negative breast cancer

Indexed keywords

DELAYED RELEASE FORMULATION; FLUORESCENT DYE; INDOCYANINE GREEN; LIPOSOME; PHOTOSENSITIZING AGENT;

ANIMAL; BREAST; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; FEMALE; FLUORESCENCE IMAGING; HUMAN; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; TEMPERATURE; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

ANIMALS; BREAST; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; FEMALE; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; LIPOSOMES; MICE, NUDE; OPTICAL IMAGING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TEMPERATURE; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84939977059     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1560-7     Document Type: Article

References (42)

1. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380-7.
2. Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist. 2006;11(9):1034-44.
3. Allison RR, Bagnato VS, Sibata CH. Future of oncologic photodynamic therapy. Future Oncol. 2010;6(6):929-40.
4. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-81.
5. Allison RR, Mota HC, Bagnato VS, Sibata CH. Bio-nanotechnology and photodynamic therapy-state of the art review. Photodiagnosis Photodyn Ther. 2008;5(1):19-28.
6. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat. 2005;4(3):283-93.
7. Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, et al. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J Control Release. 2011;152(1):21-9.
8. Huang P, Li Z, Lin J, Yang D, Gao G, Xu C, et al. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials. 2011;32(13):3447-58.
9. Lee SJ, Koo H, Lee D-E, Min S, Lee S, Chen X, et al. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials. 2011;32(16):4021-9.
10. Jeong H, Huh M, Lee SJ, Koo H, Kwon IC, Jeong SY, et al. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy. Theranostics. 2011;1:230-9.
11. Tian J, Ding L, Xu HJ, Shen Z, Ju H, Jia L, et al. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer. J Am Chem Soc. 2013;135(50):18850-8.
12. Gamal-Eldeen AM, El-Daly SM, Borai IH, Wafay HA, Abdel-Ghaffar AR. Photodynamic therapeutic effect of indocyanine green entrapped in polymeric nanoparticles and their anti-EGFR-conjugate in skin cancer in CD1 mice. Photodiagnosis Photodyn Ther. 2013;10(4):446-59.
13. Zhang Y, Qian J, Wang D, Wang Y, He S. Multifunctional gold nanorods with ultrahigh stability and tunability for in vivo fluorescence imaging, SERS detection, and photodynamic therapy. Angew Chem Int Ed Engl. 2013;52(4):1148-51.
14. Ding H, Sumer BD, Kessinger CW, Dong Y, Huang G, Boothman DA, et al. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. J Control Release. 2011;151(3):271-7.
15. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104(3):323-32.
16. Taichman GC, Hendry PJ, Keon WJ. The use of cardio-green for intraoperative visualization of the coronary circulation: evaluation of myocardial toxicity. Tex Heart Inst J. 1987;14(2):133-8.
17. Yuan A, Wu J, Tang X, Zhao L, Xu F, Hu Y. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies. J Pharm Sci. 2013;102(1):6-28.
18. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7(5):626-34.
19. Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res. 1998;55(2):146-52.
20. Desmettre T, Devoisselle J, Mordon S. Fluorescence properties and metabolic features of indocyanine Green (ICG) as related to angiography. Surv Ophthalmol. 2000;45(1):15-27.
21. Derycke A. Liposomes for photodynamic therapy. Adv Drug Deliv Rev. 2004;56(1):17-30.
22. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn Ther. 2011;8(1):14-29.
23. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60(15):1627-37.
24. Chen B, Pogue BW, Hasan T. Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv. 2005;2(3):477-87.
25. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1-2):271-84.
26. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990;268(1):235-7.
27. Turner DC, Moshkelani D, Shemesh CS, Luc D, Zhang H. Near-infrared image-guided delivery and controlled release using optimized thermosensitive liposomes. Pharm Res. 2012;29(8):2092-103.
28. Shemesh CS, Hardy CW, Yu DS, Fernandez B, Zhang H. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells. Photodiagnosis Photodyn Ther. 2014;11(2):193-203.
29. De Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC. Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol. 2011;137(2):183-92.
30. Alli E, Sharma VB, Sunderesakumar P, Ford JM. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009;69(8):3589-96.
31. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Aledavood A. The effects of combined treatment with ionizing radiation and indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B. 2012;109:42-9.
32. Lim HJ, Oh CH. Indocyanine green-based photodynamic therapy with 785 nm light emitting diode for oral squamous cancer cells. Photodiagnosis Photodyn Ther. 2011;8(4):337-42.
33. Abels C, Fickweiler S, Weiderer P, Bäumler W, Hofstädter F, Landthaler M, et al. Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res. 2000;292(8):404-11.
34. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55(1):145-57.
35. Guelluy PH, Fontaine-Aupart MP, Grammenos A, Lécart S, Piette J, Hoebeke M. Optimizing photodynamic therapy by liposomal formulation of the photosensitizer pyropheophorbide-a methyl ester: in vitro and ex vivo comparative biophysical investigations in a colon carcinoma cell line. Photochem Photobiol Sci. 2010;9(9):1252-60.
36. Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab. 2010;11(2):129-41.
37. Saxena V, Sadoqi M, Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm. 2006;308(1-2):200-4.
38. Khurana M, Ulrich S, Kim A, Moriyama Y, Netchev G, Akens MK, et al. Biodistribution and pharmacokinetic studies of a porphyrin dimer photosensitizer (Oxdime) by fluorescence imaging and spectroscopy in mice bearing xenograft tumors. Photochem Photobiol. 2012;88(6):1531-8.
39. Zheng X, Xing D, Zhou F, Wu B, Chen WR. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy. Mol Pharm. 2011;8(2):447-56.
40. Chen WR, Adams RL, Higgins AK, Bartels KE, Nordquist RE. Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. Cancer Lett. 1996;98(2):169-73.
41. Suganami A, Toyota T, Okazaki S, Saito K, Miyamoto K, Akutsu Y, et al. Preparation and characterization of phospholipid-conjugated indocyanine green as a near-infrared probe. Bioorg Med Chem Lett. 2012;22(24):7481-5.
42. Shafirstein G, Bäumler W, Hennings LJ, Siegel ER, Friedman R, Moreno MA, et al. Indocyanine green enhanced near-infrared laser treatment of murine mammary carcinoma. Int J Cancer. 2012;130(5):1208-15.